Drug
Deucravacitinib
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Folliculitis | 66 | 48.1 | 49.3 | signal |
| 2 | Mouth Ulceration | 74 | 26.4 | 27.1 | signal |
| 3 | Acne | 243 | 24.0 | 26.1 | signal |
| 4 | Oral Herpes | 34 | 13.1 | 13.3 | signal |
| 5 | Oral Pain | 33 | 11.0 | 11.1 | signal |
| 6 | Psoriasis | 174 | 10.0 | 10.6 | signal |
| 7 | Skin Burning Sensation | 78 | 8.2 | 8.4 | signal |
| 8 | Blood Triglycerides Increased | 18 | 7.6 | 7.7 | signal |
| 9 | Adverse Event | 81 | 6.6 | 6.8 | signal |
| 10 | Skin Disorder | 29 | 6.5 | 6.6 | signal |
| 11 | Erythema | 153 | 5.6 | 5.9 | signal |
| 12 | Psoriatic Arthropathy | 28 | 5.2 | 5.3 | signal |
| 13 | Insurance Issue | 10 | 5.0 | 5.1 | signal |
| 14 | Pruritus | 226 | 4.5 | 4.8 | signal |
| 15 | Therapy Interrupted | 39 | 4.2 | 4.3 | signal |
| 16 | Burning Sensation | 37 | 4.0 | 4.0 | signal |
| 17 | Stomatitis | 32 | 4.0 | 4.0 | signal |
| 18 | Pharyngeal Swelling | 5 | 3.9 | 3.9 | signal |
| 19 | Drug Effect Less Than Expected | 7 | 3.7 | 3.7 | signal |
| 20 | Colon Cancer | 7 | 3.5 | 3.5 | signal |
| 21 | Herpes Zoster | 26 | 3.4 | 3.4 | signal |
| 22 | Rash | 195 | 3.4 | 3.5 | signal |
| 23 | Product Dose Omission In Error | 12 | 3.3 | 3.4 | signal |
| 24 | Blood Creatine Phosphokinase Increased | 13 | 3.3 | 3.3 | signal |
| 25 | Chromaturia | 10 | 3.3 | 3.3 | signal |
| 26 | Erythema Multiforme | 4 | 3.2 | 3.2 | signal |
| 27 | Swelling Face | 27 | 3.1 | 3.1 | signal |
| 28 | Pharyngitis Streptococcal | 4 | 2.8 | 2.8 | no signal |
| 29 | Oral Discomfort | 5 | 2.7 | 2.7 | no signal |
| 30 | Tooth Disorder | 8 | 2.7 | 2.7 | signal |
| 31 | Lip Swelling | 11 | 2.5 | 2.5 | signal |
| 32 | Product Dispensing Error | 7 | 2.4 | 2.4 | signal |
| 33 | Skin Fissures | 6 | 2.4 | 2.4 | no signal |
| 34 | Inability To Afford Medication | 3 | 2.3 | 2.3 | no signal |
| 35 | Adverse Reaction | 4 | 2.3 | 2.3 | no signal |
| 36 | Uveitis | 4 | 2.2 | 2.2 | no signal |
| 37 | Lymphoma | 4 | 1.9 | 1.9 | no signal |
| 38 | Tuberculosis | 3 | 1.7 | 1.7 | no signal |
| 39 | Blood Glucose Abnormal | 4 | 1.6 | 1.6 | no signal |
| 40 | Therapeutic Response Shortened | 5 | 1.2 | 1.2 | no signal |
| 41 | Dermatitis Atopic | 6 | 0.9 | 0.9 | no signal |
| 42 | Pancreatic Carcinoma | 3 | 0.8 | 0.8 | no signal |
| 43 | Bladder Cancer | 3 | 0.4 | 0.4 | no signal |